These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 16098003)
1. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Adam B; Liebregts T; Saadat-Gilani K; Vinson B; Holtmann G Aliment Pharmacol Ther; 2005 Aug; 22(4):357-63. PubMed ID: 16098003 [TBL] [Abstract][Full Text] [Related]
2. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun AN; Thomson AB; Mann V; Escobedo S; Chakraborty B; Nevin K Aliment Pharmacol Ther; 2006 Feb; 23(4):521-9. PubMed ID: 16441473 [TBL] [Abstract][Full Text] [Related]
3. Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Kindt S; Dubois D; Van Oudenhove L; Caenepeel P; Arts J; Bisschops R; Tack J Neurogastroenterol Motil; 2009 Nov; 21(11):1183-e105. PubMed ID: 19663903 [TBL] [Abstract][Full Text] [Related]
4. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Mearin F; Balboa A; Zárate N; Cucala M; Malagelada JR Am J Gastroenterol; 1999 Jan; 94(1):116-25. PubMed ID: 9934741 [TBL] [Abstract][Full Text] [Related]
5. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Talley NJ; Verlinden M; Jones M Am J Gastroenterol; 1999 Sep; 94(9):2390-7. PubMed ID: 10483997 [TBL] [Abstract][Full Text] [Related]
7. Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome. Carbone F; Vandenberghe A; Holvoet L; Vanuytsel T; Van Oudenhove L; Jones M; Tack J Aliment Pharmacol Ther; 2016 Nov; 44(9):989-1001. PubMed ID: 27518319 [TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756 [TBL] [Abstract][Full Text] [Related]
9. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms]. Jebbink HJ; Smout AJ; van Berge Henegouwen GP Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822 [TBL] [Abstract][Full Text] [Related]
10. Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model. Madsen LG; Bytzer P Dig Dis; 2008; 26(3):237-42. PubMed ID: 18463442 [TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity for capsaicin in patients with functional dyspepsia. Hammer J; Führer M; Pipal L; Matiasek J Neurogastroenterol Motil; 2008 Feb; 20(2):125-33. PubMed ID: 17931342 [TBL] [Abstract][Full Text] [Related]
12. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Shinomiya T; Fukunaga M; Akamizu T; Irako T; Yokode M; Kangawa K; Nakai Y; Nakai Y Scand J Gastroenterol; 2005 Jun; 40(6):648-53. PubMed ID: 16036524 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966 [TBL] [Abstract][Full Text] [Related]
14. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Talley NJ; Tack J; Ptak T; Gupta R; Giguère M Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059 [TBL] [Abstract][Full Text] [Related]
15. The ageing gut: diminished symptom response to a standardized nutrient stimulus. Gururatsakul M; Holloway RH; Adam B; Liebregts T; Talley NJ; Holtmann GJ Neurogastroenterol Motil; 2010 Mar; 22(3):246-e77. PubMed ID: 19814772 [TBL] [Abstract][Full Text] [Related]
16. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Bastyr EJ; Price KL; Bril V; Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253 [TBL] [Abstract][Full Text] [Related]
18. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Bisschops R; Karamanolis G; Arts J; Caenepeel P; Verbeke K; Janssens J; Tack J Gut; 2008 Nov; 57(11):1495-503. PubMed ID: 18519430 [TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study. Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283 [TBL] [Abstract][Full Text] [Related]
20. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Lee KJ; Demarchi B; Demedts I; Sifrim D; Raeymaekers P; Tack J Am J Gastroenterol; 2004 Sep; 99(9):1765-73. PubMed ID: 15330916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]